Saving changes...

Done

Error

Sexual Dysfunction in the Female Patient

Sexual Dysfunction in the Female Patient

Sexual Dysfunction in the Female Patient

Maureen Whelihan, MD, FACOG and Michael Krychman, MD, FACOG
Maureen Whelihan, MD, FACOG and Michael Krychman, MD, FACOG
on behalf of American College of Obstetricians & Gynecologists

$90.00 $ 90.00 $ 90.00

$90.00 $ 90.00 $ 90.00

$ 90.00 $ 90.00 $ 90.00
$ 90.00 $ 90.00 $ 90.00
Normal Price: $90.00 $90.00

Review:

Launch date: 23 Apr 2018
Expiry Date: 30 Apr 2021

Last updated: 16 Oct 2018

Reference: 188428

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

In Sexual Dysfunction in the Female Patient, experts Maureen Whelihan, MD, FACOG and Michael Krychman, MD, FACOG explain the components of Female Sexual Interest and Arousal Disorder for diagnosis. The unit offers a review of definitions, assessment, and current, validated scales for various disorders. You will read about how to develop a referral network, review comprehensive treatment paradigms, and be aware of the prevalence of sexual dysfunction disorders among patients.

Objectives

List the 6 components of Female Sexual Interest and Arousal Disorder for List the components of Female Sexual Interest and Arousal Disorder for diagnosis.
Review studies and steps to list components of the disorder and become familiar with how and why the disorder occurs.
Explain the multifactorial nature of Female Sexual Dysfunction.
Review the varying and overlapping reasons that contribute to Female Sexual Dysfunction.
Recommend common non-pharmacologic and pharmacologic treatments.
Recommend a broad range of non-pharmacologic and pharmacologic treatments. Review what is considered dangerous.
Explain how to open the discussion with patients regarding female sexual concerns.
Consider cases and what you might say to various patients to elicit sexual history and concerns.
Maureen Whelihan, MD, FACOG and Michael Krychman, MD, FACOG

Author Information Play Video Bio

Maureen Whelihan, MD, FACOG and Michael Krychman, MD, FACOG
on behalf of American College of Obstetricians & Gynecologists

Maureen Whelihan, MD, FACOG
Gynecologist and Sexual Health Specialist
Greenacres, Florida

Michael Krychman, MD, FACOG
Gynecologist and Sexual Health Specialist
Newport Beach, California

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Continuing Medical Education (ACCME)
  • 7.00 Credits

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

Maureen Whelihan, MD, FACOG, receives funds from Valeant.

Michael Krychman, MD, FACOG, is a consultant with Applied Biology and Palatin Technologies; he is a speaker and consultant for Pfizer, Sermonix, Shionogi, and Valeant.

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error